65832-21-5,MFCD22570652
Catalog No.:AA01DIGI

65832-21-5 | methyl 2-(((trifluoromethyl)sulfonyl)oxy)cyclopent-1-enecarboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
95%
3 weeks  
$347.00   $243.00
- +
100mg
95%
3 weeks  
$488.00   $342.00
- +
250mg
95%
3 weeks  
$677.00   $474.00
- +
500mg
95%
3 weeks  
$1,033.00   $723.00
- +
1g
95%
3 weeks  
$1,306.00   $914.00
- +
2.5g
95%
3 weeks  
$2,504.00   $1,753.00
- +
5g
95%
3 weeks  
$3,679.00   $2,575.00
- +
10g
95%
3 weeks  
$5,427.00   $3,799.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01DIGI
Chemical Name:
methyl 2-(((trifluoromethyl)sulfonyl)oxy)cyclopent-1-enecarboxylate
CAS Number:
65832-21-5
Molecular Formula:
C8H9F3O5S
Molecular Weight:
274.2143
MDL Number:
MFCD22570652
SMILES:
COC(=O)C1=C(CCC1)OS(=O)(=O)C(F)(F)F
Properties

Downstream Synthesis Route

[1]Logan,AngusW.J.;Parker,JeremyS.;Hallside,MichalS.;Burton,JonathanW.[OrganicLetters,2012,vol.14,#12,p.2940-2943]

[2]Petersen,MikkelDue;Boye,SorenValdgard;Nielsen,ErikHolm;Willumsen,Jeanette;Sinning,Steffen;Wiborg,Ove;Bols,Mikael[BioorganicandMedicinalChemistry,2007,vol.15,#12,p.4159-4174]

[3]Boye,SorenV.;Ortega-Caballero,Fernando;Sinning,Steffen;Wiborg,Ove;Jensen,HenrikH.;Bols,Mikael[BioorganicandMedicinalChemistryLetters,2007,vol.17,#21,p.6019-6025]

[4]Locationinpatent:bodytextChin,Ling-Yu;Lee,Chia-Ying;Lo,Yu-Hsiang;Wu,Ming-Jung[JournaloftheChineseChemicalSociety,2008,vol.55,#3,p.643-648]

[5]Locationinpatent:schemeortableLiu,Jian;Jian,Tianying;Guo,Liangqin;Atanasova,Tzvetomira;Nargund,RaviP.[TetrahedronLetters,2009,vol.50,#37,p.5228-5230]

[6]Locationinpatent:experimentalpartBeauchard,Anne;Phillips,VictoriaA.;Lloyd,MatthewD.;Threadgill,MichaelD.[Tetrahedron,2009,vol.65,#39,p.8176-8184]

[7]Tsuji,Takashi;Yamaguchi,Mitsuhiro;Kuroyanagi,Junichi;Furuzono,Shinji;Konishi,Masahiro;Terayama,Koji;Tanaka,Jun;Saito,Motoko;Kobayashi,Yoshiyuki[BioorganicandMedicinalChemistryLetters,2019,vol.29,#14,p.1785-1790]

[8]CurrentPatentAssignee:XIAMENUNIVERSITY-WO2018/177151,2018,A1Locationinpatent:Page/Pagecolumn6

[9]Hsu,Day-Shin;Liang,Suz-Ping[JournalofOrganicChemistry,2020,vol.85,#2,p.1270-1278]

[10]Schumacher,Andreas;Schrems,MarcusG.;Pfaltz,Andreas[Chemistry-AEuropeanJournal,2011,vol.17,#48,p.13502-13509]

[11]CurrentPatentAssignee:ELILILLY&CO-WO2004/94401,2004,A1Locationinpatent:Page14

[12]Gehringer,Matthias;Mäder,Patrick;Gersbach,Philipp;Pfeiffer,Bernhard;Scherr,Nicole;Dangy,Jean-Pierre;Pluschke,Gerd;Altmann,Karl-Heinz[OrganicLetters,2019,vol.21,#15,p.5853-5857]

[13]Piers,Edward;Tse,HoiLunAllan[CanadianJournalofChemistry,1993,vol.71,#7,p.983-994]

[14]Loreto,M.Antonietta;Pompei,Federica;Tardella,PaoloA.;Tofani,Daniela[Tetrahedron,1997,vol.53,#46,p.15853-15858]

[15]Norman,BryanH.;Dodge,JeffreyA.;Richardson,TimothyI.;Borromeo,PeterS.;Lugar,CharlesW.;Jones,ScottA.;Chen,Keyue;Wang,Yong;Durst,GregoryL.;Barr,RobertJ.;Montrose-Rafizadeh,Chahrzad;Osborne,HaroldE.;Amos,RobertM.;Guo,Sherry;Boodhoo,Amechand;Krishnan,Venkatesh[JournalofMedicinalChemistry,2006,vol.49,#21,p.6155-6157]

[16]Glass,R.S.;Swedo,R.J.[JournalofOrganicChemistry,1978,vol.43,p.2291-2294]

[17]Jasperse,CraigP.;Curran,DennisP.[JournaloftheAmericanChemicalSociety,1990,vol.112,#14,p.5601-5609]

[18]Piers,Edward;Tse,HoiLunAllan[TetrahedronLetters,1984,vol.25,#30,p.3155-3158]

[19]Collini,MichaelD.;Ellingboe,JohnW.[TetrahedronLetters,1997,vol.38,#46,p.7963-7966]

[20]Kim,Hwa-Ok;Ogbu,CyprianO.;Nelson,Sherry;Kahn,Michael[Synlett,1998,#10,p.1059-1060]

[21]Christensen,HelenaS.;Boye,SorenV.;Thinggaard,Jacob;Sinning,Steffen;Wiborg,Ove;Schiott,Birgit;Bols,Mikael[BioorganicandMedicinalChemistry,2007,vol.15,#15,p.5262-5274]

[22]Ralph,MichaelJ.;Harrowven,DavidC.;Gaulier,Steven;Ng,Sean;Booker-Milburn,KevinI.[AngewandteChemie-InternationalEdition,2015,vol.54,#5,p.1527-1531][Angew.Chem.,2014,vol.54-127,#5,p.1547-1551,5]

[23]Moreau,RobertJ.;Skepper,ColinK.;Appleton,BrentA.;Blechschmidt,Anke;Balibar,CarlJ.;Benton,BretM.;Drumm,JosephE.;Feng,BrianY.;Geng,Mei;Li,Cindy;Lindvall,MikaK.;Lingel,Andreas;Lu,Yipin;Mamo,Mulugeta;Mergo,Wosenu;Polyakov,Valery;Smith,ThomasM.;Takeoka,Kenneth;Uehara,Kyoko;Wang,Lisha;Wei,Jun-Rong;Weiss,AndrewH.;Xie,Lili;Xu,Wenjian;Zhang,Qiong;DeVicente,Javier[JournalofMedicinalChemistry,2018,vol.61,#8,p.3309-3324]

[24]Chen,Mo;Su,Naijing;Deng,Tianning;Wink,DonaldJ.;Zhao,Yingwei;Driver,TomG.[OrganicLetters,2019,vol.21,#6,p.1555-1558]

[25]Yuan,Qianjia;Prater,MatthewB.;Sigman,MatthewS.[AdvancedSynthesisandCatalysis,2020,vol.362,#2,p.326-330]

16520-62-0    51411-81-5    65832-21-5   
3-(2-methoxycarbonyl-cyclopent-1-enyl)-2-phenethyl-1H-indole-6-carboxylicacid 

[1]TetrahedronLetters,1997,vol.38,p.7963-7966

930-51-8    51411-81-5    65832-21-5   
2-cyclopentyl-3-(2-methoxycarbonyl-cyclopent-1-enyl)-1H-indole-6-carboxylicacid 

[1]TetrahedronLetters,1997,vol.38,p.7963-7966

51411-81-5    65832-21-5   
3-Pent-4-ynyloxy-benzoicacidmethylester 
 
3-(2-methoxycarbonyl-cyclopent-1-enyl)-2-3-(3-methoxycarbonyl-phenoxy)-propyl-1H-indole-6-carboxylicacid 

[1]TetrahedronLetters,1997,vol.38,p.7963-7966

51411-81-5    65832-21-5    200411-41-2   
2-(4-methoxy-benzoyl)-methyl-amino-methyl}-3-(2-methoxycarbonyl-cyclopent-1-enyl)-1H-indole-6-carboxylicacid 

[1]TetrahedronLetters,1997,vol.38,p.7963-7966

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Building Blocks
More >
Historical Records
Tags:65832-21-5 Molecular Formula|65832-21-5 MDL|65832-21-5 SMILES|65832-21-5 methyl 2-(((trifluoromethyl)sulfonyl)oxy)cyclopent-1-enecarboxylate
Catalog No.: AA01DIGI
65832-21-5,MFCD22570652
65832-21-5 | methyl 2-(((trifluoromethyl)sulfonyl)oxy)cyclopent-1-enecarboxylate
Pack Size: 50mg
Purity: 95%
3 weeks
$347.00 $243.00
Pack Size: 100mg
Purity: 95%
3 weeks
$488.00 $342.00
Pack Size: 250mg
Purity: 95%
3 weeks
$677.00 $474.00
Pack Size: 500mg
Purity: 95%
3 weeks
$1,033.00 $723.00
Pack Size: 1g
Purity: 95%
3 weeks
$1,306.00 $914.00
Pack Size: 2.5g
Purity: 95%
3 weeks
$2,504.00 $1,753.00
Pack Size: 5g
Purity: 95%
3 weeks
$3,679.00 $2,575.00
Pack Size: 10g
Purity: 95%
3 weeks
$5,427.00 $3,799.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01DIGI
Chemical Name: methyl 2-(((trifluoromethyl)sulfonyl)oxy)cyclopent-1-enecarboxylate
CAS Number: 65832-21-5
Molecular Formula: C8H9F3O5S
Molecular Weight: 274.2143
MDL Number: MFCD22570652
SMILES: COC(=O)C1=C(CCC1)OS(=O)(=O)C(F)(F)F
Properties
Downstream Synthesis Route
358-23-6    10472-24-9    65832-21-5 

[1]Logan,AngusW.J.;Parker,JeremyS.;Hallside,MichalS.;Burton,JonathanW.[OrganicLetters,2012,vol.14,#12,p.2940-2943]

[2]Petersen,MikkelDue;Boye,SorenValdgard;Nielsen,ErikHolm;Willumsen,Jeanette;Sinning,Steffen;Wiborg,Ove;Bols,Mikael[BioorganicandMedicinalChemistry,2007,vol.15,#12,p.4159-4174]

[3]Boye,SorenV.;Ortega-Caballero,Fernando;Sinning,Steffen;Wiborg,Ove;Jensen,HenrikH.;Bols,Mikael[BioorganicandMedicinalChemistryLetters,2007,vol.17,#21,p.6019-6025]

[4]Locationinpatent:bodytextChin,Ling-Yu;Lee,Chia-Ying;Lo,Yu-Hsiang;Wu,Ming-Jung[JournaloftheChineseChemicalSociety,2008,vol.55,#3,p.643-648]

[5]Locationinpatent:schemeortableLiu,Jian;Jian,Tianying;Guo,Liangqin;Atanasova,Tzvetomira;Nargund,RaviP.[TetrahedronLetters,2009,vol.50,#37,p.5228-5230]

[6]Locationinpatent:experimentalpartBeauchard,Anne;Phillips,VictoriaA.;Lloyd,MatthewD.;Threadgill,MichaelD.[Tetrahedron,2009,vol.65,#39,p.8176-8184]

[7]Tsuji,Takashi;Yamaguchi,Mitsuhiro;Kuroyanagi,Junichi;Furuzono,Shinji;Konishi,Masahiro;Terayama,Koji;Tanaka,Jun;Saito,Motoko;Kobayashi,Yoshiyuki[BioorganicandMedicinalChemistryLetters,2019,vol.29,#14,p.1785-1790]

[8]CurrentPatentAssignee:XIAMENUNIVERSITY-WO2018/177151,2018,A1Locationinpatent:Page/Pagecolumn6

[9]Hsu,Day-Shin;Liang,Suz-Ping[JournalofOrganicChemistry,2020,vol.85,#2,p.1270-1278]

[10]Schumacher,Andreas;Schrems,MarcusG.;Pfaltz,Andreas[Chemistry-AEuropeanJournal,2011,vol.17,#48,p.13502-13509]

[11]CurrentPatentAssignee:ELILILLY&CO-WO2004/94401,2004,A1Locationinpatent:Page14

[12]Gehringer,Matthias;Mäder,Patrick;Gersbach,Philipp;Pfeiffer,Bernhard;Scherr,Nicole;Dangy,Jean-Pierre;Pluschke,Gerd;Altmann,Karl-Heinz[OrganicLetters,2019,vol.21,#15,p.5853-5857]

[13]Piers,Edward;Tse,HoiLunAllan[CanadianJournalofChemistry,1993,vol.71,#7,p.983-994]

[14]Loreto,M.Antonietta;Pompei,Federica;Tardella,PaoloA.;Tofani,Daniela[Tetrahedron,1997,vol.53,#46,p.15853-15858]

[15]Norman,BryanH.;Dodge,JeffreyA.;Richardson,TimothyI.;Borromeo,PeterS.;Lugar,CharlesW.;Jones,ScottA.;Chen,Keyue;Wang,Yong;Durst,GregoryL.;Barr,RobertJ.;Montrose-Rafizadeh,Chahrzad;Osborne,HaroldE.;Amos,RobertM.;Guo,Sherry;Boodhoo,Amechand;Krishnan,Venkatesh[JournalofMedicinalChemistry,2006,vol.49,#21,p.6155-6157]

[16]Glass,R.S.;Swedo,R.J.[JournalofOrganicChemistry,1978,vol.43,p.2291-2294]

[17]Jasperse,CraigP.;Curran,DennisP.[JournaloftheAmericanChemicalSociety,1990,vol.112,#14,p.5601-5609]

[18]Piers,Edward;Tse,HoiLunAllan[TetrahedronLetters,1984,vol.25,#30,p.3155-3158]

[19]Collini,MichaelD.;Ellingboe,JohnW.[TetrahedronLetters,1997,vol.38,#46,p.7963-7966]

[20]Kim,Hwa-Ok;Ogbu,CyprianO.;Nelson,Sherry;Kahn,Michael[Synlett,1998,#10,p.1059-1060]

[21]Christensen,HelenaS.;Boye,SorenV.;Thinggaard,Jacob;Sinning,Steffen;Wiborg,Ove;Schiott,Birgit;Bols,Mikael[BioorganicandMedicinalChemistry,2007,vol.15,#15,p.5262-5274]

[22]Ralph,MichaelJ.;Harrowven,DavidC.;Gaulier,Steven;Ng,Sean;Booker-Milburn,KevinI.[AngewandteChemie-InternationalEdition,2015,vol.54,#5,p.1527-1531][Angew.Chem.,2014,vol.54-127,#5,p.1547-1551,5]

[23]Moreau,RobertJ.;Skepper,ColinK.;Appleton,BrentA.;Blechschmidt,Anke;Balibar,CarlJ.;Benton,BretM.;Drumm,JosephE.;Feng,BrianY.;Geng,Mei;Li,Cindy;Lindvall,MikaK.;Lingel,Andreas;Lu,Yipin;Mamo,Mulugeta;Mergo,Wosenu;Polyakov,Valery;Smith,ThomasM.;Takeoka,Kenneth;Uehara,Kyoko;Wang,Lisha;Wei,Jun-Rong;Weiss,AndrewH.;Xie,Lili;Xu,Wenjian;Zhang,Qiong;DeVicente,Javier[JournalofMedicinalChemistry,2018,vol.61,#8,p.3309-3324]

[24]Chen,Mo;Su,Naijing;Deng,Tianning;Wink,DonaldJ.;Zhao,Yingwei;Driver,TomG.[OrganicLetters,2019,vol.21,#6,p.1555-1558]

[25]Yuan,Qianjia;Prater,MatthewB.;Sigman,MatthewS.[AdvancedSynthesisandCatalysis,2020,vol.362,#2,p.326-330]

16520-62-0    51411-81-5    65832-21-5   
3-(2-methoxycarbonyl-cyclopent-1-enyl)-2-phenethyl-1H-indole-6-carboxylicacid 

[1]TetrahedronLetters,1997,vol.38,p.7963-7966

930-51-8    51411-81-5    65832-21-5   
2-cyclopentyl-3-(2-methoxycarbonyl-cyclopent-1-enyl)-1H-indole-6-carboxylicacid 

[1]TetrahedronLetters,1997,vol.38,p.7963-7966

51411-81-5    65832-21-5   
3-Pent-4-ynyloxy-benzoicacidmethylester 
 
3-(2-methoxycarbonyl-cyclopent-1-enyl)-2-3-(3-methoxycarbonyl-phenoxy)-propyl-1H-indole-6-carboxylicacid 

[1]TetrahedronLetters,1997,vol.38,p.7963-7966

51411-81-5    65832-21-5    200411-41-2   
2-(4-methoxy-benzoyl)-methyl-amino-methyl}-3-(2-methoxycarbonyl-cyclopent-1-enyl)-1H-indole-6-carboxylicacid 

[1]TetrahedronLetters,1997,vol.38,p.7963-7966

Building Blocks More >
Submit
© 2017 AA BLOCKS, INC. All rights reserved.